Glioblasztóma: vizsgálatok itt: Hollandia
30 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Amsterdam, Groningen, Rotterdam
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - No phaseNot yet taking people in HollandiaAn Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- Boston Scientific Corporation
See details and how to joinNCT07867886 - No phaseTaking peoplePilot IntraOperative Neuronal Electrophysiology in Tumor rElatEd suRgery
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 20
- Run by
- Erasmus Medical Center
See details and how to joinNCT06617208 - 1. fázisNot yet taking people in Hollandia[¹⁸F]MC225 PET Analysis of Blood–Brain Barrier Function in Glioblastomas
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 10
- Run by
- Universitair Medisch Centrum Groningen
See details and how to join2026-526106-32-00 · EU 2026-526106-32-00 - No phaseTaking peopleTargeted Pediatric High-Grade Glioma Therapy
- Where
- Utrecht
- Életkor
- 12 hónap to 39 év
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379 - 2. fázisTaking peopleStudy of Olutasidenib and Temozolomide in HGG
- Where
- Utrecht
- Életkor
- 12 év to 39 év
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - 1. fázisNot yet taking people in HollandiaA Phase I Study using Oncolytic AdenoVirus Immunotherapy with Repeat Administrations in Recurrent GliOblastoma (VIRAGO)
- Where
- Amsterdam, Rotterdam
- Életkor
- 18 év and over
- People
- 18
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2025-524555-31-00 · EU 2025-524555-31-00 - 3. fázisTaking peopleStudy of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
- Where
- Amsterdam, Utrecht
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Telix Pharmaceuticals (Innovations) Pty Limited
See details and how to joinNCT07100730 - Korai 1. fázisTaking peopleLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Where
- Utrecht
- Életkor
- 1 év to 21 év
- People
- 15 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06333899 - 1. fázisNot yet taking people in HollandiaAn open-label dose escalation study to estimate maximum tolerated dose (MTD), identify dose-limiting toxicities (DLTs) and study pharmacokinetics following a single dose of intracranially administered temozolomide-based SI-053 as an add-on to the current standard of care (SoC), in adult patients with newly diagnosed glioblastoma (GBM).
- Where
- Rotterdam
- Életkor
- 18 év to 64 év
- People
- 27 worldwide
- Run by
- Double Bond Pharmaceutical AB
See details and how to joinNCT04967690 · EU 2024-515128-35-00 - 1. fázisTaking peopleONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Where
- Utrecht
- Életkor
- 2 év to 21 év
- People
- 208 worldwide
- Run by
- Sabine Mueller, MD, PhD
See details and how to joinNCT04732065 · EU 2025-521180-13-00 - 3. fázisTaking peopleLomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
- Where
- Leiden, Rotterdam, Tilburg
- Életkor
- 18 év and over
- People
- 411 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00 - 1/2. fázisNot yet taking people in HollandiaThe ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse glioma
- Where
- Rotterdam
- Életkor
- 18 év to 64 év
- People
- 28 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504696-24-00 · EU 2023-504696-24-00 - 1. fázisTaking peopleStudy Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 20
- Run by
- Amsterdam UMC Stichting
See details and how to join2025-522128-28-00 · EU 2025-522128-28-00 - 2. fázisTaking peopleSurgery for Recurrent Glioblastoma
- Where
- Amsterdam, Nijmegen, The Hague
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT02394626 - Korai 1. fázisTaking peoplePET-imaging of Two Vartumabs in Patients With Solid Tumors
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 32
- Run by
- Var2 Pharmaceuticals
See details and how to joinNCT06645808 · EU 2024-513827-18-00 - No phaseTaking peopleGlioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
- Where
- Amsterdam, Leiden, Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 120
- Run by
- Erasmus Medical Center
See details and how to joinNCT07121842 - 1. fázisTaking peoplePhase 0 trial of CBD in recurrent glioblastoma patients
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 7
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-513357-74-01 · EU 2024-513357-74-01 - No phaseTaking peopleHitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 53
- Run by
- Erasmus Medical Center
See details and how to joinNCT06183983 - 4. fázisNot yet taking people in HollandiaUnravelling the invisiBle infiltRating cOmponeNT Of glioblaStomA Using mRi USpio (BRONTOSAURUS)
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 15
- Run by
- Stichting Radboud universitair medisch centrum
See details and how to join2024-514013-34-00 · EU 2024-514013-34-00 - No phaseTaking peopleExtensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 30
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06623565 - 1. fázisTaking peopleMIRROR; Multispectral and bimodal fluorescent guided surgery (FGS) of high-grade glioma for refining margin assessment: A phase 1 dose finding study using Cetuximab-IRDye800CW- combined with 5-ALA
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 21
- Run by
- Universitair Medisch Centrum Groningen
See details and how to joinNCT05929456 · EU 2024-513392-40-01 - No phaseNot yet taking people in HollandiaFET-PET-Guided Management of Pseudoprogression in Glioblastoma
- Where
- Amsterdam, Enschede, Groningen, Maastricht, Nijmegen, Rotterdam, The Hague, Utrecht
- Életkor
- 18 év and over
- People
- 144
- Run by
- Veerle Ruijters
See details and how to joinNCT06480721 - No phaseTaking peopleThe RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- Where
- Rotterdam, The Hague
- Életkor
- 18 év to 90 év
- People
- 464 worldwide
- Run by
- Jasper Gerritsen
See details and how to joinNCT06283927 - No phaseTaking peopleThe SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- Where
- Rotterdam, The Hague
- Életkor
- 18 év to 90 év
- People
- 784 worldwide
- Run by
- Jasper Gerritsen
See details and how to joinNCT06118723